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W O R D S

Background: Younger breast cancer survivors face unique challenges, and research is

Adjustment

needed to better understand how to optimize their quality of life (QoL) and satisfaction

Breast cancer

with life (SwL). Objective: The aim of this study was to examine a biopsychosocial

Quality of life

model of QoL and SwL in young breast cancer survivors. Biological, psychological, and

Satisfaction with life

social/practical factors were hypothesized to be associated with both distressing and

Young survivors

adaptive reactions during survivorship, which in turn were hypothesized to be associated

Young women

with QoL and SwL. Methods: Young (age = 19-45 years at diagnosis) breast cancer
survivors (N = 284) completed an online survey assessing demographic and
biopsychosocial factors, QoL, and SwL. Latent variables were created for adaptive and
distressing reactions, and structural equation modeling was used to test the hypothesized
relationships. Results: The model fit the data (χ2(100) = 332.92, P < .001, comparative
fit index = 0.86, root mean square error of approximation = 0.09, standardized root
mean square residual = 0.05) and accounted for large proportions of variance in QoL
(R2 = 0.86) and SwL (R2 = 0.62). Social support, parenting concerns, and fertility
concerns each significantly predicted adjustment. Adaptive reactions positively predicted
SwL (β = 0.58, P < .001) but not QoL. Distressing reactions negatively predicted SwL (β =
−0.26, P < .01) and QoL (β = −0.87, P < .001). Conclusions: Adjustment in
survivorship mediated the association of social support, parenting concerns, and fertility
concerns on QoL and SwL in young breast cancer survivors. Implications for
Practice: To support the psychological adjustment of young breast cancer survivors,
attention should be given to survivors' social context including survivors' available social
support and their concerns about fertility and parenting.
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reast cancer is the most common cancer in women younger than 50 years.1 It was estimated that 276 480 women
were given a diagnosis of invasive breast cancer in the
United States in 2020,1 with approximately 11% of those
women younger than 45 years.2 Breast cancers in younger
women tend to be fast growing, of a higher grade, and hormone
receptor–negative, thus requiring more aggressive treatments (eg,
chemotherapy)3 with greater adverse effects (eg, “chemo brain”).
Younger women are also more likely to possess a BRCA mutation, which often leads to additional concerns about the increased risk of cancer in family members.4 A cancer diagnosis
may impact younger women's stage of life goals (eg, forming a
family, establishing a career), resulting in unique concerns (ie,
fertility, early menopause, body image, child rearing, financial
stability). Consequently, younger breast cancer survivors report
greater depressive symptoms, distress, anxiety, and fear of recurrence and decreased quality of life (QoL) compared with older
survivors (aged >50 years).5–7 Recognizing that younger breast
cancer survivors have specific physical, emotional, and social/
family challenges, which may be complex and multifactorial, it
is necessary to develop comprehensive interventions designed to
optimize QoL and satisfaction with life (SwL).
Adjustment to chronic illness is an ongoing process that consists of positive (adaptive) and negative (distressing) reactions.8
Positive psychosocial adjustment in the context of breast cancer
may be signified by positive mood, hope, meaning making, benefit
finding, deepened relationships, and spiritual or religious engagement. Negative adjustment may be characterized by symptoms
of anxiety and depression, and heightened cancer-specific distress.9
In the last decade, research has examined distinct trajectories of
psychological adjustment in women recently given a diagnosis of
breast cancer and found substantial heterogeneity in adjustment
from diagnosis to recovery.9,10 A large proportion of breast cancer
survivors experience positive adjustment either from the time of
diagnosis or after a period of recovery.9 Many women are able to
find benefits (eg, enhanced feelings of self-worth or mastery,
greater appreciation for life) from their cancer experience, and
younger women are particularly likely to report these positive
changes.11 Furthermore, young breast cancer survivors who are
mothers have also reported positive effects of parenthood (eg, finding meaning, social support),12,13 which may relate to lower levels
of distress.14 Still, approximately 15% of survivors are at risk for
relatively poor psychosocial adjustment from diagnosis into survivorship.9 Predictors of negative adjustment in the context of breast
cancer include mental health comorbidities such as clinical depression,5 hopelessness,15 symptom burden post treatment,16 and socioeconomic factors (ie, low income, underinsured or uninsured).17,18
Understanding survivors' psychosocial adjustment after cancer provides key insight into their QoL. Younger breast cancer
survivors experience worse physical (ie, pain, vasomotor symptoms, fatigue, and sleep disturbance), mental (ie, particularly in
the psychosocial and emotional domains), and global QoL than
older survivors.5,19–21 Furthermore, decreased QoL due to pain,
physical roles, social functioning, and mental health has been
shown to persist for up to 4 years post diagnosis in breast cancer
survivors 40 years and younger.22 Unlike measures of QoL, SwL
is a subjective evaluation of general well-being unrelated to

specific domains.23 Research has shown that breast cancer survivors have lower life satisfaction than the general population23;
however, to the best of our knowledge, no studies have used
the Satisfaction with Life Scale in young breast cancer survivors.
Few studies have reported which of the aforementioned concerns “matter most” regarding young breast cancer survivors'
QoL and SwL. Using a biopsychosocial framework,24 this research
examined the direct effects of important biological, psychological,
and social variables on young breast cancer survivors' adjustment
to survivorship and their indirect effects on QoL and SwL. The
biopsychosocial variables included were chosen based on the current literature and the authors' clinical experiences with this population. We defined “young” survivors as women who were given a
diagnosis between the ages of 19 and 45 years to represent women
who are no longer adolescents and are likely premenopausal,25 and
our sample included only women who had completed primary
treatment. We hypothesized that adaptive and distressing reactions
would mediate the influence of biopsychosocial factors on QoL
and SwL. In this way, the current study was designed to identify
predictors of QoL and SwL in young breast cancer survivors.

n

Methods

Sample Recruitment
Participants (N = 284) were recruited from multiple cancer centers in the United States, as well as online support groups, email
blasts, listservs, message boards, and social media sites. Inclusion
criteria were female, nonrecurrent breast cancer, age of 19 to 45
years and premenopausal at diagnosis, posttreatment (with the
exception of hormone or antibody therapies), English speaking,
and access to the Internet. Interested women completed a
Qualtrics survey that assessed eligibility, explained the study's
purpose and lack of financial compensation, provided comprehension questions to ensure understanding, and obtained consent before study measures were assessed. All procedures were
approved by the Colorado Multiple Institutional Review Board
(Protocol #12-1565).
Recruitment took place in 2 phases, with the first phase between June 2013 and November 2013 (n = 153) and the second
phase between January 2015 and April 2015 (n = 131). The first
phase included qualitative questions to assess whether there were
important psychosocial variables related to QoL and life satisfaction that were not included in the original model. On the basis of
qualitative feedback from participants that cognitive changes
such as “chemo brain” should be included, the second survey included all of the same questions plus a measure of perceived cognitive functioning. The sample that was analyzed included 284
participants, 37 of whom provided partial responses. Facebook
was the primary method of recruitment (60.9%), as well as online support groups (15.5%). Young Survival Coalition, a national nonprofit organization specifically focused on young
women's breast cancer, was the primary organization involved
in recruitment; 39% of participants reported that they learned
about the survey through Young Survival Coalition.
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Measures
DEMOGRAPHICS

Participants self-reported demographic variables including age,
marital status, income, number of children, state of residency,
level of education, and employment status.
BIOLOGICAL CONCERNS

BRCA, Stage, Menopause, and Time Since Treatment. Participants self-reported whether they were carriers of BRCA1 and/
or BRCA2 mutations, their stage of breast cancer (0/DCIS to
IV), whether they began menopause as a result of treatment
(yes/no), and time since treatment, with the exception of hormone and endocrine therapies.
Comorbidities. The Charlson Comorbidity Index was used to
assess for medical comorbidities, and it has been validated in
breast cancer patients.26 The Charlson Comorbidity Index provides a score using weights based on severity and risk of mortality
based on 19 preexisting medical conditions.
PSYCHOLOGICAL CONCERNS

Psychological Diagnoses. Participants indicated whether they
had a history of depression, anxiety, eating disorders, bipolar disorder, schizophrenia, panic disorder, obsessive-compulsive disorder, or any other psychological disorder.
Cognitive Symptoms. To assess subjective cognitive functioning, participants in phase 2 of recruitment (n = 112) completed
the first 3 subscales (30 items) of the Functional Assessment of
Cancer Therapy-Cognitive Function Version 327 (α = .90).
SOCIAL AND PRACTICAL CONCERNS

Fertility. Concerns about fertility were measured by the
14-item Reproductive Concerns Scale28 (α = .90), which is designed specifically for young cancer survivors.
Social Support. Participants reported on 3 domains (ie, friends,
family, significant other) of perceived social support using the
12-item Multidimensional Scale of Perceived Social Support29
(α = .95).
Parenting. Participants who had dependent children (younger than 18 years) at the time of diagnosis (n = 145, 51%) answered the Parenting Concerns Questionnaire30 (α = .92), a
15-item measure of distress specifically related to parenting during cancer. Specifically, participants indicated their practical and
emotional concerns regarding their children, the impact of an illness on their child(ren), and, if they co-parent, the co-parent's
ability to care for the child(ren).
Finances. Participants completed the Financial Problems subscale of the Quality of Life in Adult Cancer Survivors instrument31
(α = .89), which consists of 4 items measuring cancer-specific financial concerns.
ADAPTIVE REACTIONS

Hope. Participants also completed the 11-item Adult Hope
Scale33 (α = .88), which assesses perceived capability to reach
one's goals.
Positive Impact of Children. The Positive Impact of Children
Scale was developed for the current study to measure the positive
effects of dependent children during cancer. The scale items were
written based on themes within the qualitative literature about
motherhood during breast cancer. The Positive Impact of Children
Scale contains 5 items including “my children gave me a reason to
fight the cancer” and “having children helped me focus on the positive.” The scale had good internal consistency (α = .83) among participants who had dependent children at the time of diagnosis.
DISTRESSING REACTIONS

Anxiety and Depression. The 2 subscales of the 14-item Hospital
Anxiety and Depression Scale34 (anxiety, α = .90; depression,
α = .86) were used to assess anxiety and depression symptoms during the past week.
Distress. The 22-item Impact of Events Scale Revised35 (α = .94)
measured distress associated with participants' cancer diagnosis.
Fear of Recurrence. Participants also completed the first 4
items of the Concerns about Recurrence Scale36 (α = .94) to assess the frequency, potential for upset, consistency, and intensity
of fears about cancer recurrence.
QUALITY OF LIFE AND SWL

Quality of Life. Quality of life was assessed using the 37-item
Functional Assessment of Cancer Therapy for Breast Cancer37
(α = .94). There are 5 subscales, which are added together to
create a global measure of health-related QoL. These subscales
measure 16 more discrete parts of QoL, including physical
well-being, social/family well-being, functional well-being,
and additional concerns.
Satisfaction With Life. Participants reported perceived life satisfaction on the 5-item Satisfaction with Life Scale23 (α = .92),
which has been found to correlate highly with other measures
of subjective well-being.

Data Analysis
Descriptive statistics were run using SPSS software to examine
distributions of study variables. Correlations among predictors
and between predictors and outcomes were examined. Once statistical assumptions necessary for structural equation modeling
were considered, a confirmatory factor analysis was run using
Mplus 8 to determine the fit of the data with the hypothesized latent
variables. All models used full information maximum likelihood to
handle missing data. Upon confirming that the 2 hypothesized
latent variables fit the data well, the entire hypothesized structural model was estimated.
n

Benefit Finding. Participants completed the 15-item Benefit
Finding Scale32 (α = .86), which assessed diverse potential benefits (ie, family and social relationships, life priorities, spirituality,
career goals, self-control, acceptance) that result from the otherwise distressing nature of cancer.
QoL and SwL in Young Breast Cancer Survivors

Results

Sample Description
In our sample of nonrecurrent young breast cancer survivors,
mean age was 40 years. Most participants were White (88.7%),
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partnered (73.6%), working full- or part-time (79.9%), and college educated (73.6%). Participants were from 39 different states,
with the largest proportions being from Colorado (14.4%) and
California (9.2%). The vast majority of participants were diagnosed with nonmetastatic disease (94.7%), which is to be expected because women who were in active treatment were not
eligible to participate. Participants were several years from diagnosis (mean, 5.4 years), and 58.9% completed treatment within
the past 3 years. Many treatment combinations were reported including chemotherapy (80.3%), mastectomy (76.1%), and radiation (55.6%). Only 3.85% of women were still undergoing
hormone and/or antibody therapy. Demographic and medical
characteristics of participants are presented in Table 1.

Measurement Models
First, a confirmatory factor analysis tested the measurement of
the 2 latent variables: distressing reactions and adaptive reactions.
Hope, benefit finding, and positive impact of children were indicators of adaptive reactions. All factor loadings were significant

(P < .001). Hope had the strongest standardized loading
(βHope = 0.72, βBenefit finding = 0.59, βPostiveImpactofChildren = 0.35).
Overall model fit indices were not produced as the model was
just-identified.
The “distressing reactions” measurement model fit the data well:
χ2(2) = 25.70, P < .001, comparative fit index = 0.94, and standardized root mean square residual = 0.047. Anxiety, traumatic distress,
depression, and fear of recurrence were indicators of distressing reactions. All path estimates were significant at P < .001. Standardized factor loadings for the indicators of distressing reactions were as follows:
βAnxiety = 0.93, βTraumaticDistress = 0.79, βDepression = 0.68, and
βFearofRecurrence = 0.62.

Correlations
Correlations between latent variables and the measured predictors in the model with QoL and life satisfaction were examined
and can be found in Table 2. Nearly all model constructs significantly correlated with QoL and SwL and were in the hypothesized direction.

Table 1 • Demographic and Medical Characteristics of Participants (N = 284)
Variable
Race/ethnicity
White
Hispanic
Asian/Pacific Island
Black
Other

Age, years
Time of survey
Time of diagnosis

Total

Variable

n (%)
252 (88.7)
14 (4.9)
6 (2.1)
5 (1.8)
7 (2.5)

Time since treatment
≤6 mo
7–11 mo
12–23 mo
2y
3y
4y
≥5 y

Mean (SD)
40.0 (6.7)
35.5 (5.3)

Total

Time since diagnosis, years

n (%)
41 (15.8)
26 (8.6)
50 (17.6)
29 (10.2)
19 (6.7)
28 (9.9)
68 (23.9)
Mean (SD)
5.4 (4.6)

Relationship status
Partnered
Single

n (%)
209 (73.6)
75 (26.4)

Current treatment
None
Antibody therapy
Hormone therapy
Antibody and hormone

n (%)
273 (96.1)
6 (2.1)
4 (1.4)
1 (.35)

Education
College degree
No college degree

n (%)
209 (73.6)
75 (26.4)

Menopause onseta
Due to treatment
Not due to treatment

n (%)
70 (24.6)
60 (21.1)

Employment status
Employed full-time
Employed part-time
Unemployed
Unable to work

n (%)
183 (64.4)
44 (15.5)
38 (13.3)
19 (6.7)

BRCA
No mutation
Unsure
BRCA1 mutation
BRCA2 mutation

n (%)
197 (69.4)
34 (12)
20 (7.0)
20 (7.0)

Stage
0/DCIS
I
II
III
IV
Unsure

n (%)
19 (6.7)
64 (22.5)
135 (47.5)
51 (18)
9 (3.2)
6 (2.1)

Past treatmentb
Mastectomy
Chemotherapy
Lumpectomy
Radiation
Antibody therapy
Hormone therapy
Reconstruction
Prophylactic surgery

n (%)
216 (76.1)
223 (80.3)
97 (34.2)
158 (55.6)
57 (20.1)
112 (39.4)
196 (69.0)
66 (22.2)

a

The question to assess menopause onset as a result of cancer treatment was only shown to a subset of the sample (n = 130).
Participants selected all treatments they had received; these totals will not equal 100%.

b
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Table 2 • Bivariate Correlations Between Modeled
Variables and Outcomes of Quality of
Life and Life Satisfaction

Variable
Quality of life
Life satisfaction
Adaptive reactions
Hope
Benefit finding
Positive impact of children
Distressing reactions
Depression
Anxiety
Fear of recurrence
Traumatic distress
Financial concerns
Social support
Parenting concerns
Fertility
Psychological diagnoses
Cognitive decline
Stage
Charlson comorbidity index
Time since diagnosis
BRCA positive

Quality of Life

Life Satisfaction
0.70a

0.70a
0.63a
0.40a
0.18b

0.66a
0.47a
0.25a

−0.81a
−0.71a
−0.49a
−0.65a
−0.49a
0.46a
−0.71a
−0.29a
−0.34a
−0.64a
−0.17a
−0.22a
0.22a
0.07

−0.64a
−0.50a
−0.24a
−0.42a
−0.38a
0.37a
−0.64a
−0.34a
−0.28a
−0.32a
−0.18a
−0.19a
0.11
0.06

a

P < .01.
P < .05.

b

Structural Equation Model
The hypothesized structural model is illustrated in the Figure. The
model incorporates each of the aforementioned biopsychosocial
factors that were hypothesized to impact the 2 adjustment constructs, which in turn were expected to predict QoL and SwL.
The biopsychosocial factors were individually measured variables; they are grouped together in the Figure for ease of understanding the model. Circles indicate latent (ie, unmeasured)
variables. The absence of a connecting line between 2 variables
implies that there is no direct effect hypothesized between those
2 variables. All exogenous variables in the model were allowed to
correlate with one another. The model fit the observed data adequately: χ2(100) = 332.92, P < .001, comparative fit index = 0.86,
root mean square error of approximation = 0.09, and standardized
root mean square residual = 0.05. The final model accounted for
86% and 62% of the variance in QoL and SwL, respectively.
The Figure shows standardized estimates.
Three of the 4 social factors significantly predicted both
adaptive and distressing reactions. Higher levels of social support
(β = 0.30, P < .0001), fewer parenting concerns (β = −0.36,
P < .01), and fewer concerns about fertility (β = −0.19,
P < .01) all significantly predicted more adaptive reactions. These
same 3 variables significantly predicted distressing reactions:
lower levels of social support (β = −0.25, P < .0001), more concerns about parenting (β = 0.58, P < .0001), and more concerns
about fertility (β = 0.17, P < .01). The other social factors did not
significantly predict either latent variable. Adaptive and distressing
reactions were significantly negatively associated with one another
QoL and SwL in Young Breast Cancer Survivors

(β = −0.67, P < .0001). None of the biological or psychological
factors was a significant predictor of either adaptive reactions or
distressing reactions. That is, having a BRCA mutation, later
stage of cancer, onset of menopause due to treatment, greater
medical comorbidity, and length of time since completing treatment were not significant predictors of the latent variables, nor
were greater cognitive decline or psychological diagnoses.
Adaptive reactions were positively associated with SwL
(β = 0.58, P < .0001), but it was not significantly related to
health-related QoL when considered as a predictor with
distressing reactions in the model. Distressing reactions were negatively related to both SwL (β = −0.26, P = .01) and
health-related QoL (β = −0.87, P < .001). The 2 outcomes of
QoL and SwL were significantly associated with one another,
even after controlling for the variance accounted for by their
shared predictors in the model (β = 0.19, P < .05).
n

Discussion

This study tested a model of psychosocial adjustment among young
breast cancer survivors to understand which biopsychosocial factors
predict adjustment and, in turn, have the greatest influence on QoL
and SwL. Of the biological, psychological, and social/practical predictors examined (see Figure), only social support, parenting, and
fertility concerns were significantly related to adjustment. Although
the findings that social support, parenting, and fertility concerns
have a significant influence on adjustment are consistent with previous research,5,12,13,28 it is notable that nonmodifiable biological variables, such as presence of BRCA mutation and stage of cancer, may
be less impactful to young survivors than possibly expected. It may
seem that more aggressive cancers would largely impact psychological adjustment, but our findings suggest that adjustment is more influenced by social rather than biological variables. This may be due,
in part, to the sample being several years post diagnosis and treatment. Thus, social factors may be more salient than biological factors to young survivors after treatment is complete.
Similarly, the finding that a previous psychiatric diagnosis does
not necessarily impact adjustment is notable and may be explained
by several factors. Participants may have received psychiatric treatment, which may serve as a protective factor. A small number of
patients endorsed a previous psychiatric diagnosis, limiting power
to test this association. Participants may have been unaware of previous psychiatric diagnoses, leading to a false-negative response.
Alternatively, adjustment for young survivors may, in part, be independent of previous mental health diagnoses. Therefore, in considering the biopsychosocial concerns of young survivors,
healthcare providers should discuss survivors' social relationships
and influences. Specifically, survivors may benefit from greater
consultation regarding social support, fertility preservation (among
those who wish to consider having children), and parenting concerns. Previous work28 has emphasized that young survivors want
greater information, support, and coordination of care when navigating the complex issues surrounding their reproductive health
and parenthood. Beyond the social factors examined in this research, clinicians should also consider additional social concerns
and role negotiations.
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Figure Results for hypothesized structural equation model of psychosocial adjustment among young breast cancer survivors,
both significant and nonsignificant path estimates included (significant paths in bold). *P < .05, **P < .01, ***P < .001.
In addition to examining predictors of adjustment, we hypothesized that the latent variables of adaptive and distressing reactions would mediate the influence of biopsychosocial factors
on QoL and SwL. Our hypothesis was partially supported by
the data. Distressing reactions (measured by depression, anxiety,
fear of recurrence, and traumatic distress) were strongly associated with reduced QoL and SwL, and depression accounted for
the majority of the variance. Compared with other samples of
young breast cancer survivors, our sample had relatively lower
QoL scores, which may be a result of response bias in our recruitment strategy.38 Distressing reactions were more strongly associated with reduced QoL compared with SwL, which may be due
to the fact that QoL measures emotional distress whereas SwL
does not. Furthermore, as QoL and SwL are unique constructs,
an individual may be overall satisfied with his/her life although
specific domains of QoL (eg, physical QoL) may be negatively
impacted by cancer survivorship. Unlike distressing reactions,
adaptive reactions (measured by hope, benefit finding, and positive impact of children) were only associated with higher levels of
SwL. Adaptive reactions most strongly loaded on hope; current
findings are in line with previous research39 that found maintaining a hopeful outlook regarding meeting one's goals and aspirations is especially salient for young women who may be in the
early stages of meeting their life goals. It is perhaps surprising that
adaptive reactions were not a significant predictor of QoL. However, it is important to recognize that all 3 indicators of adaptive
reactions, particularly hope, were positively correlated with QoL.
In the tested model, distressing reactions were an extremely
strong predictor of QoL; thus, when controlling for the effect
of distressing reactions, there was little residual variance in QoL

to predict. It is of note that the positive impact of dependent children was not significantly associated with parenting concerns,
suggesting that having concerns about one's children and finding
meaning from parenting throughout one's cancer experience may
be mutually exclusive. Finally, distressing and adaptive reactions
mediated the associations of social support, parenting concerns,
and fertility concerns with QoL and SwL, underscoring the importance of examining complex relationships between these psychosocial factors and variables such as fear of recurrence, depression, and
anxiety.

Study Limitations
Participants self-selected to participate, and most survivors were
recruited from online support groups and advocacy websites.
Thus, our final sample reflects women who were motivated to
share their experiences and may be systematically different from
those who were uninterested in participation or were not involved in the recruitment organizations. Participants were almost
entirely White and of relatively high socioeconomic status, and
therefore, the results may not generalize to breast cancer survivors
of ethnic minority backgrounds or those of a lower socioeconomic
status. Previous research has demonstrated racial and socioeconomic disparities in breast cancer treatment and mortality rates,
which may negatively impact QoL in some minority groups.40,41
Furthermore, few women had a BRCA mutation, a late-stage disease, or medical comorbidities, which may have led to insufficient
power to detect significant effects between biological factors and
adjustment. Similarly, few women had previous mental health diagnoses, and measures of cognitive concerns were only completed
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by half of the sample (n = 112) because of it being added midway
through the study recruitment. Furthermore, biological and psychological data were collected retrospectively by self-report; thus,
survivors may have forgotten information or underreported (ie, desirability bias) psychological concerns. Because most survivors were
within 5 years of treatment completion, the results may not generalize
to women undergoing active treatment or in long-term survivorship.
Finally, we used a cross-sectional design with data collected in 2013
and 2015, and thus, results may not generalize to the modern day.
Specifically, advances in comprehensive breast cancer treatment
programs addressing survivorship and overall QoL may result
in different outcomes. Future research should use a longitudinal
design to understand how these concerns impact adjustment
throughout survivorship.
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Despite the aforementioned limitations, this research is novel in
several ways. To the best of our knowledge, no other study has
examined young breast cancer survivors' SwL. Thus, the relationships between adaptive and distressing reactions and QoL with
SwL are new to the psycho-oncology literature. Furthermore,
few studies have examined parenting concerns and the impact
of dependent children on young breast cancer survivors' adjustment. Our findings warrant future research on the experience
of being both a mother and a survivor. Additional strengths of
this work include the broad assessment of biopsychosocial functioning and the support for adjustment being a mediator of the
impact of functioning on QoL and SwL. Our various recruitment methods allowed us to gather data from women with diverse treatment experiences. Finally, breast cancer research has
historically focused on older women (>50 years old), and this
work prioritized the unique needs of younger survivors.
In conclusion, this research used a biopsychosocial model of
adjustment to examine young breast cancer survivors' QoL and
SwL. Considering “what matters most” for young breast cancer
survivors' adjustment, clinicians should focus on survivors' social
context and inquire about survivors' social support, and their
concerns about fertility and parenting. Furthermore, psychiatric
treatment specifically targeting hope, including agency and confidence in one's ability to meet their life goals, and hope regarding recovery, may improve SwL. Future research should further
explore these findings in more diverse samples and at various
time points throughout survivorship. In addition, a greater
mechanistic understanding of how survivors' social concerns influence adjustment is warranted. Young breast cancer survivors
are a growing population with unique needs. As such, efforts to
promote QoL and SwL in this population are critical.

9. Stanton AL, Bower JE. Psychological adjustment in breast cancer survivors.
Adv Exp Med Biol. 2015;862:231–242.
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